ILM-FAN VA INNOVATSIYA
ILMIY-AMALIY KONFERENSIYASI
in-academy.uz/index.php/si
47
FEATURES COMPLIANCE OF PATIENT ADHERENCE IN THE TREATMENT OF
CHRONIC HEART FAILURE
Ikromova F. A.
Bukhara State Medical Institute
https://doi.org/10.5281/zenodo.14050166
Relevance.
Today, the problem ofchronic heart failure (CHF) in modern society remains
socially and medically relevant due to its significant prevalence, high level of disability and
mortality. The studied data from long-term studies indicate insufficient secondary prevention
of CHF both at the population level and among people with a high risk of developing it. Among
the reasons for this situation, a special place is given to insufficient adherence of patients to
drug and non-drug therapy. Studying the attitude of patients to prescribed therapy and the
degree of its compliance is a fairly new area of scientific research. The development of this
direction is due to the large role of the paradigm of doctor-patient interaction, the transition
from the paternalistic model to partnership relations, and the patient's awareness of his own
active role in therapy.
Purpose of the study.
Adaptation and implementation опросниковof medication
monitoring questionnaires in the treatment of patients with CHF, and evaluation of their
effectiveness in improving patient compliance.
Material and methods of research.
The study included 74 patients with CHF. The
mean age of the patients was 68.28±0.70 years. Gender distribution: 46 women (62.2%) and
28 men (37.8%).All patients received outpatient treatment
(
с4.36±0.15 on the first days of
treatment).
When interviewing patients and analyzing the contents of home first-aid kits, a
significant number of available medications were identified (minimum – 2, maximum – 19).
The prevailing amount of drugs even with a significant volume of prescriptions could
accumulate in patients only if the medication regimen was constantly violated and they were
regularly received on preferential prescriptions. In the first-aid kits of individual patients, the
number of drugs for the treatment of concomitant pathology reached 18 items (on average,
8.7±7.16). A survey using the Morisky–Green test found only 18.1±3.7% of patients were
compliant with the therapy.
Results.
Observations of patients who received treatment for 3 months showed that
patients in the main group had significantly higher compliance rates according to the results
of the Morisky-Green scale and higher quality of life indicators compared with patients in the
control group. Based on the demonstrated effectiveness, accessibility and simplicity, the
proposed method can be recommended for implementation in a wide medical.
References:
1.
Ab E., Denig P., Ton van Vliet, Dekke J. Reasons of general practitioners for not
prescribing lipid-lowering medication to patients with diabetes: a qualitative study // BMC
Family Practice.- 2009. - №1471.- Р.10-24.
2.
Gilutz H. Computerized Community Cholesterol Control (4C): Meeting the Challenge of
Secondary Prevention // IMAJ.- 2009.- Vol. 11.- Р.33-36
ILM-FAN VA INNOVATSIYA
ILMIY-AMALIY KONFERENSIYASI
in-academy.uz/index.php/si
48
3.
Devabhaktuni M., Bangalore S. Fixed combination of amlodipine and atorvastatin in
cardiovascular risk management: patient perspectives // Vascular Health and Risk
anagement. - 2009.- № 5.- Р.377-387.
4.
Sawada N. Persistence and compliance to antidepressant treatment in patients with
depression: A chart review // BMC Psychiatry.- 2009.- Vol. 1471, № 244X.- Р.9-38.
5.
Lakatos P.L. Use of new once-daily 5-aminosalicylic acid preparations in the treatment of
ulcerative colitis: Is there anything new under the sun? // World J Gastroenterol. - 2009.- №
15.- Р.1799-1804..
